Document is current
Any future updates will be listed below
-
Authors
Siddiqi, Sarosh
Klomjit, Nattawat
Jiang, Kai
Conley, Sabena M.
Zhu, Xianyang
Saadiq, Ishran M.
Ferguson, Christopher M.
Tang, Hui
Lerman, Amir
Lerman, Lilach O. https://orcid.org/0000-0002-3271-3887
-
Funding
Funding for this research was provided by:
Novo Nordisk (Novo Nordisk)
NIH (DK120292)
- License Information
-
More Information
Article History
Accepted: 8 August 2022
First Online: 1 September 2022
Declarations
:
: Dr. Lerman is an advisor to AstraZeneca, CureSpec, and Butterfly Biosciences. The authors declare no conflict.
: This study was approved by the Mayo Clinic Institutional Review Board.
: All participants included in this study provided written informed consent.
: All authors have read and approved this manuscript for submission.
